Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Neupharma Inc patents


Recent patent applications related to Neupharma Inc. Neupharma Inc is listed as an Agent/Assignee. Note: Neupharma Inc may have other listings under different names/spellings. We're not affiliated with Neupharma Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Neupharma Inc-related inventors


Certain chemical entities, compositions, and methods

Chemical entities that are novel compounds, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc

Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of using these chemical entities, e.g., for treatment of cancer are described.... Neupharma Inc

Certain chemical entities, compositions, and methods

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc

Certain chemical entities, compositions, and methods

Chemical entities that are quinoxaline kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc

Substituted quinazolines for inhibiting kinase activity

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc

Certain chemical entities, compositions, and methods

Chemical entities based on quinoxaline that are kinase inhibitors are described. Specifically quinoxaline derivatives of Formula I, containing a diarylamide or diarylurea substructure that inhibit Braf mutant kinase activity, pharmaceutical compositions containing the inhibitor compounds and methods of treatment of cancer comprising administering an effective amount of the Braf inhibitor... Neupharma Inc

Certain chemical entities, compositions, and methods

Chemical entities that are novel compounds, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc

Certain chemical entities, compositions, and methods

Chemical entities that are effective as kinase inhibitors, pharmaceutical compositions and methods of treatment are disclosed. The chemical entities disclosed specifically inhibit signal transduction and cellular proliferation by modulating the activity of protein kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism. The compounds include a... Neupharma Inc

Substituted quinoxalines as b-raf kinase inhibitors

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.... Neupharma Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Neupharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Neupharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###